Random C-peptide in the classification of diabetes

Area of Science:

• Endocrinology
• Diabetes Mellitus Research
• Clinical Diagnostics

Background:

• Accurate diabetes classification is crucial for effective treatment.
• Distinguishing between type 1 and type 2 diabetes can be challenging.
• C-peptide levels reflect endogenous insulin production.

Purpose of the Study:

• To evaluate the utility of random C-peptide (rCP) measurements in classifying diabetes.
• To compare the diagnostic power of rCP with fasting (fCP) and glucagon-stimulated (gCP) C-peptide tests.
• To determine optimal cut-off values for C-peptide assays in diabetes subtyping.

Main Methods:

• Analysis of C-peptide measurements from a large diabetic population.
• Comparison of three C-peptide testing protocols: random (rCP), fasting (fCP), and glucagon-stimulated (gCP).
• Utilized Receiver Operating Characteristic (ROC) curves to assess discriminative power and identify optimal cut-off values.

Main Results:

• All C-peptide tests demonstrated significant discriminative power.
• Random C-peptide (rCP) showed superior ability in differentiating type 1 from type 2 diabetes compared to fCP and gCP.
• Optimal cut-off values were identified: rCP at 0.50 nmol/L, fCP at 0.42 nmol/L, and gCP at 0.60 nmol/L.

Conclusions:

• Random C-peptide testing is a powerful and recommended tool for classifying diabetes.
• rCP offers greater diagnostic accuracy than fCP and gCP for distinguishing diabetes types.
• The findings support the use of rCP as a practical classification method, especially in outpatient settings.